Enhancing Language Function in Aphasia

Recruiting N/A Interventional Study
Aphasia, Acquired Language Disorders Primary Progressive Aphasia Stroke, Cerebrovascular
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
University of Arizona · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Aphasia is an acquired impairment of language, that commonly results from damage to language areas in the brain (typically the left side of the brain). This impairment is seen in many aspects of language, including understanding, speaking, reading and writing. It is estimated that about 2 million individuals are currently living with aphasia in the United States. Further, about 200,000 Americans a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Present with speech-language impairment (aphasia) caused by stroke or dementia 2. A medical diagnosis of primary progressive aphasia (PPA) by a neurologist or physician 3. Are native speakers of English 4. Present with no contraindications for MRI 5. Have adequate (normal or …
Contacts

Aneta Kielar, PhD

15204883791

akielar@email.arizona.edu

CONTACT

Fatima Jebahi, MS

fjebahi@email.arizona.edu

CONTACT